Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05485064
Other study ID # QYFYKYLL 916711920
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 1, 2022
Est. completion date November 3, 2022

Study information

Verified date November 2022
Source The Affiliated Hospital of Qingdao University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is mainly about the feasibility and rationality of moderate sedation combined with acupuncture anesthesia in the application of gastroscopy and colonoscopy ,Then we evaluate the effectiveness and advantages of the combination of acupuncture anesthesia and drug anesthesia.


Description:

With the increase of the proportion of the patients who crave for performing painless gastroscopy and colonoscopy in recent years, it is crucial to seek a more secure and effective method of anesthesia or sedation. At present, the universal anesthetic method on gastroscopy and colonoscopy in China is the general anesthesia without intubation which usually uses propofol and opioid analgesics,Although the satisfaction of patients is high, the incidence of anesthesia-related complications and drug-related adverse reactions is high .The incidence of adverse events during the gastroscopy and colonoscopy is high, and the medical expense of anesthesia is high. At present, more than 2/3 of the patients undergo painless gastroscopy or colonoscopy are middle-aged and elderly patients, so the overdose which prolongs the recovery time、discharge time of patients and reduces the recovery quality of patients is common. The moderate sedation, which fundmentally does not affect hemodynamics、autonomous respiration and protective reflexes, is incomparable to general anesthesia . And acupuncture anesthesia also acts as a safe anesthetic method can provide safer analgesic effect.Theoretically,the combination of both of them is a relatively perfect and safe painless method.


Recruitment information / eligibility

Status Completed
Enrollment 108
Est. completion date November 3, 2022
Est. primary completion date November 3, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: 1. Outpatients 2. Patients with ASA grade I-III 3. A sufficient level of education to understand study procedures and can communicate with investigators. Exclusion Criteria: 1. Patients with serious systemic diseases such as severe cardiopulmonary disease or hepatic diseases or renal diseases. 2. Patients under the age of 18. 3. Patients who did not sign the informed consent form. 4. Patients who have a history of alcohol abuse or drug abuse. 5. People who are allergic to anesthetic related ingredients, such as soybeans, eggs and so on. 6. Patients with extreme fear or anxiety about acupuncture. 7. Patients with relative contraindications of gastrointestinal endoscopy. -

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
fentanyl
The investigator 1 use fentanyl to sedate patients coordinate with remimazolam
Procedure:
eletroacupuncture(transcutaneous electrical acupuncture point stimulation )
The investigator 1 use electroacupunture(transcutaneous electrical acupuncture point stimulation )to coordinate with remimazolam
Drug:
placebo needle
The investigator 1 use placebo needle to sedate patients coordinate with remimazolam
remimazolam
The investigator 1 use remimazolam to sedate patients coordinate with eletroacupuncture(transcutaneous electrical acupuncture point stimulation )or placebo needle

Locations

Country Name City State
China Jixiangyu Qingdao Shandong

Sponsors (1)

Lead Sponsor Collaborator
The Affiliated Hospital of Qingdao University

Country where clinical trial is conducted

China, 

References & Publications (5)

Chen JM, Li DD, Chen YS, Lian B, Wang XP, Guo YH, Xu XL, Huang P, Chen TF, Liu Y, Liu QQ. The effectiveness of electro-acupuncture combined with dyclonine hydrochloride in relieving the side effects of gastroscopy: a controlled trial. Ann Palliat Med. 202 — View Citation

Cohen LB, Hightower CD, Wood DA, Miller KM, Aisenberg J. Moderate level sedation during endoscopy: a prospective study using low-dose propofol, meperidine/fentanyl, and midazolam. Gastrointest Endosc. 2004 Jun;59(7):795-803. — View Citation

Eberl S, Monteiro de Olivera N, Bourne D, Streitberger K, Fockens P, Hollmann MW, Preckel B. Effect of electroacupuncture on sedation requirements during colonoscopy: a prospective placebo-controlled randomised trial. Acupunct Med. 2020 Jun;38(3):131-139. doi: 10.1136/acupmed-2017-011459. Epub 2020 Jan 22. — View Citation

Qin Z, Ding Y, Xu C, Kwong JSW, Ji Y, Wu A, Wu J, Liu Z. Acupuncture vs Noninsertive Sham Acupuncture in Aging Patients with Degenerative Lumbar Spinal Stenosis: A Randomized Controlled Trial. Am J Med. 2020 Apr;133(4):500-507.e20. doi: 10.1016/j.amjmed.2019.08.038. Epub 2019 Sep 13. — View Citation

Yu B, Hazlewood PJ, Yin X, Li S, Yue H, Xu K, Xu S, Mi Y. Effect of electroacupuncture on discomfort during gastroscopy: a study protocol for a randomized controlled trial. Trials. 2022 Apr 27;23(1):364. doi: 10.1186/s13063-022-06165-4. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary patient satisfaction with sedation instrument,PSSI The investigator 2 needs to use VAS scores to evaluate satisfaction about sedation feeling when they accepted gastroscopy and colonoscopy .The score ranges from 0 to10 and need patients evaluate it by themself when the gastroscopy or colonoscopy were finished.The score from 0 (extremely dissatisfied)to 10(extremely satisfied). During gastroscopy and colonoscopy
Primary clinical satisfaction with sedation instrument,CSSI The investigator 2 needs to use VAS scores to evaluate satisfaction about doctors when they carry out the operation.The score from 0 (extremely dissatisfied)to 10(extremely satisfied). During gastroscopy and colonoscopy
Primary patient's pain score The investigator 2 needs to use VAS scores to evaluate patients' pain score .The score from 0 (extremely dissatisfied)to 10(extremely satisfied). During gastroscopy and colonoscopy
Secondary the extent of cardia exposure The investigator 2 needs to record the extent of cardia exposure to evaluate these interventions'effect on gastroscopy ,the investigator 2 use the table of the extent of preventriculus exposure(score from 1 to 4,1=the extent of exposure lower than 25%;2=the extent of exposure between 25% and 50%;3=the extent of exposure between 50%and 75%;4=the extent of exposure between 75%and 100%) During gastroscopy and colonoscopy
Secondary adverse reactions The investigator 2 needs to record the adverse reactions such as nausea?emesis, salivation, restlessness, and breath holding to analyze efficacy of relate treatment. During gastroscopy and colonoscopy
Secondary patient's recovery time The investigator 2 needs to record to evaluate patient's recovery quality about patients The end of gastroscopy and colonoscopy
Secondary patient's departure time The investigator 2 needs to record patient's departure time to evaluate recovery quality about patients The end of gastroscopy and colonoscopy
Secondary time to resume normal operation The investigator 2 needs to record the time to resume normal operation about patient The end of gastroscopy and colonoscopy
Secondary operation time about gastrointestinal endoscopy The investigator 2 needs to record operation time about gastrointestinal endoscopy. During gastroscopy and colonoscopy
Secondary heart rate The investigator 2 needs to record heart rate(for example 60 times/min)before gastrointestinal endoscopy ?during gastrointestinal endoscopy and the end of gastrointestinal endoscopy respectively.(tachycardia:heart rate is more than 100 times/min;bradycardia:heart rate is less than 60 times/min) before gastrointestinal endoscopy?during gastrointestinal endoscopy and the end of gastrointestinal endoscopy
Secondary pulse oximetry The investigator 2 needs to record pulse oximetry (for example 97% )before gastrointestinal endoscopy ?during gastrointestinal endoscopy and the end of gastrointestinal endoscopy respectively.(hypoxemia:pulse oximetry is lower than 90%) before gastrointestinal endoscopy?during gastrointestinal endoscopy and the end of gastrointestinal endoscopy
Secondary systolic pressure ?diastolic pressure The investigator 2 needs to record systolic pressure ?diastolic pressure(for example 120/75mmHg ) before gastrointestinal endoscopy ?during gastrointestinal endoscopy and the end of gastrointestinal endoscopy respectively.(hypertension:systolic pressure =140mmHg or diastolic pressure =90mmHg;hypotension:systolic pressure =90mmHg or diastolic pressure =60mmHg) before gastrointestinal endoscopy?during gastrointestinal endoscopy and the end of gastrointestinal endoscopy
Secondary respiratory rate The investigator 2 needs to record respiratory rate(for example 15 times/min)before gastrointestinal endoscopy ?during gastrointestinal endoscopy and the end of gastrointestinal endoscopy respectively.(tachypnea:respiratory rate is more than 20 times/min;bradypnea:respiratory rate is less than 12 times/min) before gastrointestinal endoscopy?during gastrointestinal endoscopy and the end of gastrointestinal endoscopy
See also
  Status Clinical Trial Phase
Recruiting NCT05222048 - Endoscopy Needs of People in Suichang County, Lishui City, Zhejiang Province, China
Completed NCT05103696 - A Comparative Study of Rimazolam and Propofol Combined With Etomidate in Gastroenteroscopy in Elderly Patients N/A
Completed NCT04123821 - The Routine Use of Nasopharyngeal Airway in the Setting of Monitored Anesthesia Care During Gastrointestinal Endoscopy N/A
Recruiting NCT04879771 - Comparison of Receiving Painless Gastrointestinal Endoscopy in the Morning or Afternoon on Postoperative Sleep Quality
Completed NCT01941888 - Propofol TCI Administered by Gastroenterologists During Endoscopy: a Randomized Double Blind Controlled Study Phase 4
Completed NCT03829293 - High-Flow Nasal Oxygenation Versus Standard Oxygenation in Gastrointestinal Endoscopy With Sedation. N/A
Completed NCT00952458 - Bispectral Index Monitoring of Sedation During Endoscopic Retrograde Cholangiopancreaticography N/A
Completed NCT03669068 - Gastrointestinal Endoscopy in Patients With Prothrombotic Conditions: THE ENDOHEM REGISTRY
Completed NCT03632330 - Sedation Of Adult Patients Undergoing Gastrointestinal Endoscopy: A Network Meta-analysis
Completed NCT01189604 - Dose Rate Range Finding Study of Propofol for minimal-to Moderate Sedation on Upper & Lower Endoscopic Tests Phase 2
Completed NCT05414435 - Informed Consent in Endoscopy: Read, Understood or Merely Signed?
Completed NCT04656964 - Comparison Between Remimazolam Tosilate and Midazolam in Elderly Patients Undergoing Gastrointestinal Endoscopy N/A